Heart failure & cardiomyopathiesCohort study

Cardiomyopathies in children and adolescents: aetiology, management, and outcomes in the European Society of Cardiology EURObservational Research Programme Cardiomyopathy and Myocarditis Registry

Eur Heart JPublished

  • Prospective registry study
  • multicentre
  • 23 referral centres in 14 countries

Authors' conclusion

The findings confirm the heterogeneous aetiology of childhood cardiomyopathies and show a high frequency of familial disease. Outcomes differed by cardiomyopathy subtype

Study context

Population
Children and adolescents with cardiomyopathy, ESC EURObservational Cardiomyopathy and Myocarditis Registry (June 2014–December 2016)aged ≤18 years
Participants
633 children
Exposure
HCM vs DCM vs RCM vs ARVC
  • HCMn = 388
  • DCMn = 206
  • RCMn = 28
  • ARVCn = 11

Main finding

As reported in the abstract

Baseline characteristics
Median age at diagnosis (IQR 0-10)
4.0 years
Male
372 (58.8%)
Receiving cardiac medication
621 (98.1%)
ICD
80 (12.6%)
Familial disease
253/535, 47.3%
Genetic testing performed
414 (67.8%)
Pathogenic or likely pathogenic variant among tested
250 (60.4%)
Rare disease phenocopies
177 (28.0%)

Observational data: associations, not effects.

Further findings

OutcomeHCMDCMRCMARVC
Death · median follow-up 12.5 months (IQR 11.3-15.3 months)2.6%3.0%16.0%Not reported in the abstract
HF eventsNot reported in the abstractNot reported in the abstract36.0%Not reported in the abstract
Death — Overall deaths
18 (3.3%)

Rare disease phenocopies, age <10 vs ≥10 years

Under 10 years vs older
142 (30.9%) vs. 35 (19.6%); P = .003

HF events

Most frequent in RCM

Original publication

Cardiomyopathies in children and adolescents: aetiology, management, and outcomes in the European Society of Cardiology EURObservational Research Programme Cardiomyopathy and Myocarditis Registry. Eur Heart J. Published 1 March 2024. doi:10.1093/eurheartj/ehae109

Summarised from the published abstract; every number is checked against it